"Triple-hormone-receptor agonist retatrutide for obesity a phase 2 trial." NEJM
The two should not be confused
Without proper regulatory oversight, patients may receive medications with inconsistent potency, contamination, or incorrect ingredients
Always check with your pharmacy for the exact instructions on how to store semaglutide and its expiration date
(Tirzepatide has not been tested or FDA-approved in pill form, but that hasn't stopped some companies from trying to sell it.) Despite the inconvenience of an injection, use of these medications has become widespread
It is worth noting, however, that gastric emptying effects with incretin therapies may attenuate with continued dosing, and the clinical relevance of any absorption change varies considerably between medicines